Cargando…
Emergency department administration of COVID-19 antibody therapies: Early experience
Autores principales: | Payette, Christopher, Brooks, Joseph T., Shesser, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934759/ https://www.ncbi.nlm.nih.gov/pubmed/33714645 http://dx.doi.org/10.1016/j.ajem.2021.03.001 |
Ejemplares similares
-
Hand Sanitizer Intoxication in the Emergency Department
por: Pourmand, Ali, et al.
Publicado: (2021) -
Rethinking Traditional Emergency Department Care Models in a Post-Coronavirus Disease-2019 World
por: Pourmand, Ali, et al.
Publicado: (2023) -
Perceived barriers to COVID-19 vaccine administration in Emergency Department
por: Goodwin, Tress, et al.
Publicado: (2022) -
Emergency Department-based monoclonal antibody therapy for patients with mild to moderate COVID-19
por: Devlin, Amanda, et al.
Publicado: (2023) -
Bradykinin-induced angioedema in the emergency department
por: Hébert, Jacques, et al.
Publicado: (2022)